Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
about
Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growthBAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growthThe lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cellsHepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptorCentral memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cellsT cell homeostatic proliferation elicits effective antitumor autoimmunityLymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaBImmune response and immunopathology during toxoplasmosisRetinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesisDirect interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptorTRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissuesThe intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the gamesAutoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunityCoordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissuesInducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the LungHow Follicular Dendritic Cells Shape the B-Cell AntigenomeControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentRole of Tumor Necrosis Factor Superfamily in Neuroinflammation and AutoimmunityLymphotoxin and TNF: how it all began-a tribute to the travelersLinking the microbiota and metabolic disease with lymphotoxinThe Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunityBoth functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malariaAntigen recognition by autoreactive CD4⁺ thymocytes drives homeostasis of the thymic medullaStromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic InflammationHigh Endothelial Venules and Lymphatic Vessels in Tertiary Lymphoid Organs: Characteristics, Functions, and RegulationEctopic Tertiary Lymphoid Tissue in Inflammatory Bowel Disease: Protective or Provocateur?The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cellsEndogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosisSerine/threonine kinase activity associated with the cytoplasmic domain of the lymphotoxin-beta receptor in HepG2 cellsTWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosisCD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growthTRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptorCharacterizing follicular dendritic cells: A progress reportAbrogation of the alternative complement pathway by targeted deletion of murine factor BChallenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, micePI3K p110δ is expressed by gp38(-)CD31(+) and gp38(+)CD31(+) spleen stromal cells and regulates their CCL19, CCL21, and LTβR mRNA levelsCharacterization of tumor necrosis factor-deficient miceChemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulationAbnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient miceUnique Features of Fish Immune Repertoires: Particularities of Adaptive Immunity Within the Largest Group of Vertebrates
P2860
Q22003914-C5D15B79-6E71-4463-A429-738222754268Q22009942-DE1FEF08-9BA0-4370-BC91-A063C725BB45Q22254033-CFDFFAFD-0E47-44AC-B730-B7C4AC85CA51Q24313170-79E56BBF-CDC1-4271-BCCB-F99B9134C6AAQ24530100-E8988F18-5A06-4566-A624-851A726883DDQ24553060-8120E715-2B78-47FB-8662-25AC899ACCFDQ24564927-C69C10EA-58D7-44D0-95E6-DBFCBB66EFA2Q24612341-6B499B90-9430-4A32-BB42-4CFE135AB418Q24642725-B6A78273-5912-49AB-AB87-1FE1D34EDC89Q24653498-9A773FCD-1DDB-475F-AACC-8434DB77E85EQ24678181-454AEE46-411A-4756-9BBB-5BBB3AE33124Q24683018-8E0B181A-94C1-42D9-ADBD-F3D7D967AF9CQ24684338-AEBAB38B-D1FB-4AE1-90E3-32EA5104D3E4Q24685416-80495E38-E88F-43D9-9C35-BB46AB3114E2Q26742160-72A30534-7C6B-4223-BAF6-C3FF6810650AQ26742173-4C6E467F-3AE6-4128-977B-9F1067D33FE2Q26799117-9A46A6F5-D303-48FF-8FFB-E5E1087921D3Q26800155-FD6B6DF7-9CA1-457F-9D93-8E7FDF17CAEDQ26865649-5EB4F520-3B39-4E51-885E-8D55B18DB51FQ26996602-8D11BF64-BF9F-4250-8B34-2441E514D8A5Q27025082-37796D85-1F73-463C-981A-C3EADE051AF8Q27300897-8CE4497F-FF18-406D-932A-0F56FFEB56E1Q27324446-1E5BAA56-CF62-4C3B-89B2-7F5B3D9E2302Q28068106-6819AC1D-6F2A-4F14-99BB-B6C3FFEFC8E7Q28069933-3F6E582C-7B20-4119-9F87-051E75E95DCCQ28077990-8967E9FC-D2EB-49B5-9047-38EC5B19F1AEQ28141786-D325444A-E3AF-42DB-93BE-E5D28C915D4BQ28207830-936E1BEC-CC11-4CE5-96E0-28BA3596B63CQ28242190-7FAB54E9-4C95-42D5-8509-CB9B85BF02FAQ28257134-181646EB-4B65-478B-8994-DE87865E5BB9Q28274504-B0469B39-8F95-4826-946D-AB6B682EFCD2Q28282051-64522574-EDA2-4534-AAD2-E536B19F1D43Q28293692-CF3A00B6-16E9-4300-8045-689481011C4DQ28506022-D1456DEF-722F-48FB-918B-113CC57C9CF3Q28506176-B2B532F0-9C56-45AA-AE0E-AAD0C37CA547Q28512141-4CDBCFD0-A5A7-4C5A-A9DC-9F2C4CF5A2B6Q28512785-79F7C224-3E38-4220-AFBE-1F5422BD26FAQ28585797-884C8FEC-1676-488F-ADDB-1A5141F622CAQ28587099-094D984B-F204-4CF6-BEA0-7CB29923077FQ28592953-392EE67A-C796-4E4A-8EE7-1106CF70BBBE
P2860
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
description
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Science
@fr
artículu científicu espublizáu en 1994
@ast
im April 1994 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1994/04/29)
@sk
vědecký článek publikovaný v roce 1994
@cs
wetenschappelijk artikel (gepubliceerd op 1994/04/29)
@nl
наукова стаття, опублікована у квітні 1994
@uk
name
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@ast
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@en
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@nl
type
label
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@ast
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@en
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@nl
prefLabel
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@ast
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@en
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@nl
P2093
P3181
P356
P1433
P1476
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
@en
P2093
J. Goellner
J. Strauss-Schoenberger
N. H. Ruddle
P. De Togni
P. R. Streeter
R. Carlson
S. C. Smith
S. Mariathasan
P304
P3181
P356
10.1126/SCIENCE.8171322
P407
P577
1994-04-29T00:00:00Z